Instituto Portugues De Oncologia Do Porto Francisco Gentil E.P.E.

The clinical research activity at Instituto Português de Oncologia do Porto Francisco Gentil E.P.E. is centered on non-small cell lung cancer, with particular attention to early-stage and locally advanced unresectable disease. The sponsor’s trial portfolio reflects a focus on treatment pathways for patients considered for radical local therapy.

• Non-Small Cell Lung Cancer
• Early-Stage Lung Cancer
• Locally Advanced Unresectable Disease
• Radical Local Treatment

Research interest extends to disease settings where systemic and local therapies are combined in the management of thoracic malignancy.